{"id":"W2754562397","doi":"10.1016/s2213-8587(17)30313-3","title":"Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":596,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"National Institute for Health and Care Research; Amgen","keywords":"Medicine; Evolocumab; PCSK9; Internal medicine; Diabetes mellitus; Type 2 diabetes; Clinical endpoint; Myocardial infarction; Stroke (engine); Cardiology; Endocrinology; Clinical trial; Cholesterol; Lipoprotein","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003621245,0.0003334657,0.003805685,0.0001434466,0.0002353751,0.00002034574,0.0003891352,0.0001308736,0.000003278406],"category_scores_gemma":[0.003222241,0.0001291001,0.0007185828,0.000252506,0.002091504,0.00005042598,0.0003150552,0.0004327233,5.40402e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000254601,"about_ca_system_score_gemma":0.00007711291,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003504481,"about_ca_topic_score_gemma":0.0000678331,"domain_scores_codex":[0.9952999,0.002329172,0.0007350509,0.000415452,0.0006509048,0.0005695506],"domain_scores_gemma":[0.9941064,0.002351155,0.0009457315,0.002397271,0.0001227319,0.00007673099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1786697,0.00006471456,0.8003591,0.0001917297,0.01177249,2.749984e-7,0.0003562601,0.00004111903,0.00006154458,0.00003193429,0.000008088487,0.008442989],"study_design_scores_gemma":[0.3984165,0.001150967,0.5894805,0.0001755014,0.008054108,5.840859e-7,0.00001950664,0.0002292353,0.00231944,0.00004555184,0.00002825823,0.00007984786],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867901,0.006441586,0.000001543774,0.0003826096,0.0001041018,0.00613515,0.00007696363,0.000007576199,0.00006034244],"genre_scores_gemma":[0.9987324,0.0008788853,0.00001935645,0.00004657599,0.0001131272,0.0001708596,0.00000421914,0.00002268142,0.00001191548],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2197467,"threshold_uncertainty_score":0.7706233,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007369601405536356,"score_gpt":0.238387942603715,"score_spread":0.2310183411981787,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}